Tumour necrosis factor alpha induces only minor inflammatory changes in the central nervous system, but augments experimental meningitis

Neuroscience

Volumn 86, Issue 2, 1998, Pages 627-634

  Angstwurm, K ^a   Freyer, D ^a   Dirnagl, U ^a   Hanisch, U K ^b   Schumann, R R ^a,b   Einhaupl K M ^a   Weber, J R ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Cytokine; Experimental; Meningitis; Nitric oxide

Indexed keywords

AMINOGUANIDINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; CELL WALL; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; HYPOTHESIS; INFLAMMATION; INTRACRANIAL PRESSURE; MENINGITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; RAT; WATER CONTENT;

ANIMALS; BODY WATER; BRAIN; CELL WALL; CEREBROVASCULAR CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANIDINES; INFLAMMATION; INTRACRANIAL PRESSURE; LEUKOCYTE COUNT; MALE; MENINGITIS, PNEUMOCOCCAL; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; REGIONAL BLOOD FLOW; STREPTOCOCCUS PNEUMONIAE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032100553     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00032-3     Document Type: Article

References (42)

1. Angstwurm K., Weber J. R., Segert A., Bürger W., Weih M., Freyer D., Einhäupl K. M., Dirnagl U. Fucoidin, a polysaccharide inhibiting leukocyte rolling, attenuates inflammatory responses in experimental pneumococcal meningitis in rats. Neurosci. Lett. 191:1995;1-4.
2. Baudry N., Vicaut E. Role of nitric oxide in effects of tumor necrosis factor-alpha on microcirculation in rat. J. appl. Physiol. 75:1993;2392-2399.
3. Bereta M., Bereta J., Cohen S., Cohen M. C. Low density lipoprotein inhibits accumulation of nitrites in murine brain endothelial cell cultures. Biochem. biophys. Res. Commun. 186:1992;315-320.
4. Bereta M., Bereta J., Georgoff I., Coffman F. D., Cohen S., Cohen M. C. Methylxanthines and calcium-mobilizing agents inhibit the expression of cytokine-inducible nitric oxide synthase and vascular cell adhesion molecule-1 in murine microvascular endothelial cells. Expl Cell Res. 212:1994;230-242.
5. Beutler B. TNF, immunity and inflammatory disease, lessons of the past decade. J. invest. Med. 43:1995;227-235.
6. Boje K. M. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis. Brain Res. 720:1996;75-83.
7. Claudio L., Martiney J. A., Brosnan C. F. Ultrastructural studies of the blood retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha. Lab. Invest. 70:1994;850-861.
8. Durand M. L., Calderwood S. B., Weber D. J., Miller S. I., Southwick F. S., Caviness V. S. Acute bacterial meningitis in adults. A review of 493 episodes. New Engl. J. Med. 328:1993;21-28.
9. Durieu-Trautmann O., Federici C., Creminon C., Foignant Chaverot N., Roux F., Claire M., Strosberg A. D., Couraud P. O. Nitric oxide and endothelin secretion by brain microvessel endothelial cells, regulation by cyclic nucleotides. J. Cell Physiol. 155:1993;104-111.
10. Estrada C., Gómez C., Martín C. Effects of TNF-α on the production of vasoactive substances by cerebral endothelial and smooth muscle cells in culture. J. cerebr. Blood Flow Metab. 15:1995;920-928.
11. Freyer D., Weih M., Weber J. R., Bürger W., Scholz P., Manz R., Ziegenhorn A., Angstwurm K., Dirnagl U. Pneumococcal cell wall components induce nitric oxide synthase and TNF-alpha in astroglial enriched cultures. Glia. 16:1996;1-6.
12. Gutierrez E. G., Banks W. A., Kastin A. J. Murine tumor necrosis factor alpha from blood to brain in the mouse. J. Neuroimmunol. 47:1993;169-176.
13. Haberl R. L., Anneser F., Koedel U., Pfister H. W. Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis? Neurol. Res. 16:1994;108-112.
14. Hartung T., Wendel A. Endotoxin-inducible cytotoxicity in liver cell cultures. Biochem. Pharmac. 42:1991;1129-1135.
15. Hauser S. L., Doolittle T. H., Lincoln R., Brown R. H., Dinarello C. A. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology. 40:1990;1735-1739.
16. Kim K. S., Wass C. A., Cross A. S., Opal S. M. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res. 11:1992;293-298.
17. Koedel U., Bernatowicz A., Paul R., Frei K., Fontana A., Pfister H. W. Experimental pneumococcal meningitis, cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann. Neurol. 37:1995;313-323.
18. Leist T. P., Frei K., Kam-Hansen S., Zinkernagl R. M., Fontana A. Tumor Necrosis Factor alpha (TNF alpha) in CSF during bacterial, but not viral meningitis, evaluation in murine model infections and in patients. J. exp. Med. 167:1988;1743-1748.
19. Lindauer U., Villringer A., Dirnagl U. Characterization of the CBF response to somatosensory stimulation, the model and influence of anaesthetics. Am. J. Physiol. 264:1993;H1223-H1228.
20. Liu T., Clark R. K., McDonnell P. C., Young P. R., White R. F., Barone F. C., Feuerstein G. Z. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke. 25:1994;1481-1488.
21. Matsuda M., Tsukada N., Miyagi K., Yanagisawa N. Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy. J. Neuroimmunol. 52:1994;33-40.
22. Merrill J. E., Ignarro L. J., Sherman M. P., Melinek J., Lane T. E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
23. Mustafa M. M., Ramilo O., Olsen K. D., Franklin P. S., Hansen E. J., Beutler B., McCracken G. H. Tumor necrosis factor in mediating experimental Haemophilus influenzae Type B meningitis. J. clin. Invest. 84:1989;1253-1259.
24. París M. M., Friedland I. R., Stuart E., Hickey S. M., Olsen K. D., Hansen E., Thonar E. J., McCracken G. H. Effect of interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor in animal models of infection. J. inv. Dis. 171:1995;161-169.
25. Pfister H. W., Fontana A., Täuber M. G., Tomasz A., Scheld W. M. Mechanisms of brain injury in bacterial meningitis, workshop summary. Clin. Infect. Dis. 19:1994;463-479.
26. Pfister H. W., Koedel U., Haberl R. L., Dirnagl U., Feiden W., Ruckdeschel G., Einhäupl K. Microvascular changes during the early phase of experimental bacterial meningitis. J. cerebr. Blood Flow Metab. 10:1990;914-922.
27. Quagliarello V., Scheld M. Bacterial meningitis, pathogenesis, pathophysiology, and progress. New Engl. J. Med. 327:1992;864-872.
28. Quagliarello V., Wispelwey B., Long W. J., Scheld M. Recombinant human Interleukin 1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J. clin. Invest. 87:1991;1360-1366.
29. Raine C. S. The Dale E. McFarlin lecture, the immunology of the multiple sclerosis lesion. Ann. Neurol. 36:1994;S61-S72.
30. Ramilo O., Saez Llorens X., Mertsola J., Jafari H., Olsen K. D., Hansen E. J., Yoshinaga M., Ohkawara S., Nariuchi H., McCracken G. H. Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J. exp. Med. 172:1990;497-507.
31. Saija A., Princi P., Lanza M., Scalese M., Aramnejad E., De Sarro A. Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci. 56:1995;775-784.
32. Saukkonen K., Sande S., Cioffe C., Wolpe S., Sherry B., Cerami A., Tuomanen E. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J. exp. Med. 171:1990;439-448.
33. Sharief M. K., Ciardi M., Thompson E. J. Blood-brain barrier damage in patients with bacterial meningitis, association with tumor necrosis factor-alpha but not interleukin-1 beta. J. infect. Dis. 166:1992;350-358.
34. Shohami E., Novikov M., Bass R., Yamin A., Gallily R. Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J. cerebr. Blood Flow Metab. 14:1994;615-619.
35. Stearman M., Southgate H. J. The use of cytokine and C-reactive protein measurements in cerebrospinal fluid during acute infective meningitis. Ann. clin. Biochem. 31:1994;255-261.
36. Täuber M. G., Shibl A., Hackbarth C. J., Larrick J. W., Sande M. A. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J. infect. Dis. 156:1987;456-461.
37. Taupin V., Toulmond S., Serrano A., Benavides J., Zavala F. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J. Neuroimmunol. 42:1993;177-185.
38. Tracey K. J. (1994) Tumour necrosis factor-alpha. In: The Cytokine Handbook, 2nd edn, pp. 289-304. Academic, New York.
39. Tuomanen E., Tomasz A., Hengstler B., Zak O. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J. infect. Dis. 151:1985;536-540.
40. Tureen J. Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit, role of nitric oxide. J. clin. Invest. 95:1995;1086-1091.
41. Weber J. R., Angstwurm K., Bürger W., Einhäupl K. M., Dirnagl U. Anti-ICAM-1 (CD54) monoclonal antibody reduces inflammatory changes in experimental bacterial meningitis. J. Neuroimmunol. 63:1995;63-68.
42. Zhang F., Casey R. M., Ross M. E., Iadecola C. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke. 27:1997;317-323.